Immuron Limited - Warrants (12/05/2022) Accounts Payable

As of the most recent data (December 2025), IMRNW shows a accounts payable of $1.5M. That compares with $1.3M in the prior-year period — up 16.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMRNW's accounts payable is now $1.5M (was $1.3M) — a 16.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Immuron Limited - Warrants (12/05/2022) is outperforming or lagging.

Tracking IMRNW's accounts payable over time shows whether Immuron Limited - Warrants (12/05/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.5M That compares with $1.3M in the prior-year period — up 16.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Immuron Limited - Warrants (12/05/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1.5M) with ownership activity and broader fundamentals.

Immuron Limited - Warrants (12/05/2022)'s accounts payable is $1.5M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.